1. Home
  2. ELOX vs NA Comparison

ELOX vs NA Comparison

Compare ELOX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$13.20

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

NA

Nano Labs Ltd

BUY

Current Price

$1.70

Market Cap

51.9M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
ELOX
NA
Founded
1999
2019
Country
United States
China
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
51.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ELOX
NA
Price
$13.20
$1.70
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $38.25
N/A
AVG Volume (30 Days)
17.7K
★ 20.9K
Earning Date
08-12-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$10.00
$1.58
52 Week High
$23.40
$5.16

Technical Indicators

Market Signals
Indicator
ELOX
NA
Relative Strength Index (RSI) 40.05 36.72
Support Level $10.74 $1.69
Resistance Level $14.65 $1.96
Average True Range (ATR) 1.28 0.16
MACD -0.04 -0.03
Stochastic Oscillator 21.89 12.46

Price Performance

Historical Comparison
ELOX
NA

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: